We are a charity and rely on donations

Charity Number: 1117194 (England and Wales)

Registered Company: 06000961

Registered address:
Shift.ms, Platform, New Station Street, LS1 4JB, United Kingdom

London office:
Shift.ms, Somerset House, Strand, West Goods Entrance, London WC2R 1LA, United Kingdom

©2024 Shift.ms

@Aditya_Kumar_Sahni 

Last reply

Aditya_Kumar_Sahni

Xemys - therapeutic vaccination for MS

Hey! Has anybody heard of the therapeutic vaccination for MS being investigated in the institute of bio organic chemistry in Russia ? I once read an article posted in 2016 where in a person from that Institute claimed that the vaccination would be out in the market after 2020.
4
@Stumbler
@Stumbler
 

@aditya_kumar_sahni , I found this update on the Pharmasynthez website (http://pharmsynthez.com/?p=5050) :- "at the end of 2019, we will begin the registration phase of the clinical trials of the Xemys therapeutic vaccine for the treatment of multiple sclerosis, which will end in the next few years. This unique drug has promising prospects for the treatment of patients suffering from multiple sclerosis, ”the manager emphasized."

@Aditya_Kumar_Sahni
@Aditya_Kumar_Sahni
 

@stumbler thank you for sharing this, but the language used here in the page is not English, how did you translate? Btw I am very disappointed to know that even the clinical trials haven't begun. No earlier than 2025 to see this in the market.